Our medical team is developing, researching and refining various treatment options for cornea disorder in close collaboration with NIIOS R&D and Amnitrans EyeBank Rotterdam. The clinical results can be found in national and international medical research journals, and they are being presented at national and international ophthalmology congresses.
You can read about several clinical results for (advanced) DMEK (Descemet membrane endothelial keratoplasty), including for treating Fuchs endothelial dystrophy and bullous keratopathy and Bowman layer transplants for keratoconus.
Quick vision recovery in DMEK
DMEK results in quicker vision recovery than DSEK (Descemet stripping endothelial keratoplasty) or a full cornea transplant (PKP):
Reduced risk of donor tissue rejection
In addition to quicker vision recovery, DMEK offers lower transplant rejection rates than DSEK and penetrating keratoplasty.
Hardly any long-term complications have been recorded following DMEK. Complications like permanently impaired vision or long-term glaucoma are much less frequent than following DSEK or PKP. In approximately 13% of eyes, the transplant does not sufficiently bond following DMEK surgery. In some cases, additional treatment is required. The surgical insertion of a bubble behind the donor tissue allows the transplant to bond.
The results of Bowman layer transplants for advanced, progressive keratoconus
Plan vrijblijvend een afspraak met een van onze specialisten.
Maak een afspraak